We are SmallCaps.Us

  • Smallcaps is an online platform that introduces and follows-up high potential U.S. and Canadian small cap stocks.
  • We publish unique content about those companies every Saturday.
  • Why you should sign up for our newsletter? Because an average gain of 210% since 2003 proves that our small cap picks are also perfect for your portfolio.

Latest Articles

Legal Troubles At Hemispherx

Now that we finally started to see some light at the end of the New Drug Application (NDA) tunnel for Hemispherx Biopharma (HEB – $1.00) , they seem to have sailed into murky legal waters. Since its November 2 press release, in which the Company gave an update on its NDA for Ampligen, several law firms have filed a class […]

Read more

New BUY Recommendation: DAC Technologies Group Int’l

The five stocks that we recommended in 2009 have done very well so far. At today’s closing prices, our five recommendations: Hemispherx Biopharma (HEB), Orsus Xelent (ORS), Boots & Coots (WEL), Acme United (ACU) and Global Green Solutions (GGRN) are up between 30 and 370 percent, or +127% on average. Obviously, it’s impossible to predict if our following recommendations will […]

Read more

Acme United’s Board Approves New Stock Repurchase Program And Dividend – Stock Reaches $10 Per Share

On Wednesday, Acme United Corporation (ACU – $10.00) announced excellent news when its Board of Directors approved a new stock repurchase program of up to 200,000 common shares. This new program goes on top of 49,335 shares that may still be repurchased under its previous program, which was announced in December of 2008. To get this in perspective, 249,335 shares […]

Read more

Global Green Solutions’ Aera Project Picked Up In Major Newspaper

The Bakersfield Californian, one of California’s leading newspapers, published a very interesting article about two multimillion-dollar renewable energy projects being developed in Kern County, California, USA. One of these projects is the Global Green Solutions’ (GGRN – $0.14) Greensteam project at Aera Energy, one of California’s largest oil and gas producers. If you haven’t read the article yet, we strongly […]

Read more

Hemispherx Biopharma’s Influenza Results

It’s very unfortunate Dr. Hasegawa wasn’t able to attend the Annual Conference of the Japanese Society For Vaccinology held in Sapporo, Japan on September 27, 2009. Although an abstract was published on the Hemispherx website, we feel as if the investment community only glanced over the presentation. To help us clarify the abstract, we had a conference call this week […]

Read more

Hemispherx Expands Its Manufacturing Facilities

We also received positive news from our biotech stock Hemispherx Biopharma (HEB – $2.05). The Company will spend up to $4.4 million for engineering studies, capital improvements, system upgrades, and introduction of building management systems to enhance production for Alferon N and its two experimental therapeutics Alferon LDO and Ampligen. These investments will bring the capacity of Hemispherx’ manufacturing site […]

Read more
1 112 113 114 115 116 118